In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...